Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Recent Approaches to Mrna Vaccine Delivery by Lipid-Based Vectors Prepared by Continuous-Flow Microfluidic Devices Publisher Pubmed



Toudeshkchouei MG1 ; Tavakoli A2 ; Mohammadghasemi H8 ; Karimi A3 ; Ai J4 ; Rabiee M5 ; Rabiee N6, 7
Authors

Source: Future Medicinal Chemistry Published:2022


Abstract

Advancements in nanotechnology have resulted in the introduction of several nonviral delivery vectors for the nontoxic, efficient delivery of encapsulated mRNA-based vaccines. Lipid- and polymer-based nanoparticles (NP) have proven to be the most potent delivery systems, providing increased delivery efficiency and protection of mRNA molecules from degradation. Here, the authors provide an overview of the recent studies carried out using lipid NPs and their functionalized forms, polymeric and lipid-polymer hybrid nanocarriers utilized mainly for the encapsulation of mRNAs for gene and immune therapeutic applications. A microfluidic system as a prevalent methodology for the preparation of NPs with continuous flow enables NP size tuning, rapid mixing and production reproducibility. Continuous-flow microfluidic devices for lipid and polymeric encapsulated RNA NP production are specifically reviewed. © 2022 Newlands Press.
Related Docs
View other Related Docs
1. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
2. The Clinical Impact of Mrna Therapeutics in the Treatment of Cancers, Infections, Genetic Disorders, and Autoimmune Diseases, Heliyon (2024)
3. In Vivo Gene Delivery Mediated by Non-Viral Vectors for Cancer Therapy, Journal of Controlled Release (2020)
Experts (# of related papers)
View all Related Experts
Farid Dorkoosh (3)
Fatemeh Atyabi (2)
Other Related Docs
4. Enhancing Sirna Cancer Therapy: Multifaceted Strategies With Lipid and Polymer-Based Carrier Systems, International Journal of Pharmaceutics (2024)
5. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)
6. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
7. Nanobionics: From Plant Empowering to the Infectious Disease Treatment, Journal of Controlled Release (2022)
8. Recent Advances in Sirna Delivery Systems for Prostate Cancer Therapy, Current Pharmaceutical Biotechnology (2022)
9. Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers, ACS Applied Bio Materials (2022)
10. Characterization of Stability, Safety and Immunogenicity of the Mrna Lipid Nanoparticle Vaccine Iribovax® Against Covid-19 in Nonhuman Primates, Journal of Controlled Release (2023)
11. Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review, Vaccines (2023)
12. A State-Of-The-Art Review on Solid Lipid Nanoparticles As a Nanovaccines Delivery System, Journal of Drug Delivery Science and Technology (2023)
13. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
14. Nanomedicine “New Food for an Old Mouth”: Novel Approaches for the Treatment of Covid-19, Drug Delivery Letters (2023)
15. Application of Nano-Based Systems for Drug Delivery and Targeting: A Review, Journal of Nanoparticle Research (2020)
16. Nanocarrier-Based Gene Delivery for Immune Cell Engineering, Journal of Materials Chemistry B (2024)
17. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
18. Recent Advances on Biocompatible and Biodegradable Nanoparticles As Gene Carriers, Expert Opinion on Biological Therapy (2016)
19. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
20. Comparison of Immune Response Between Sars, Mers, and Covid-19 Infection, Perspective on Vaccine Design and Development, BioMed Research International (2021)